Controlling and Monitoring Intracellular Drug Delivery Using PHPMA-Based Polymer Nanomedicines

Polymer nanomedicine is an attractive approach for the delivery of anticancer drugs. Firstly designed to increase drug bioavailability, polymer conjugates and polymer nanoparticles have rapidly emerged in the field of cancer therapy after the discovery of the enhanced permeation and retention (EPR) effect. The leaky and disordered tumor neovascularization provides opportunities to guide the accumulation of polymer nanomedicines to the tumor tissue therefore enhancing therapy selectivity and reducing off-target-associated side effects. However, since many chemotherapeutics act on targets that are located in well-defined subcellular compartments, controlling the intracellular fate of polymer nanomedicines and/or their payload is another important factor that contributes to therapy efficiency. Polymer conjugates and polymer nanoparticles generally access the cell interior via endocytosis. The physiochemical and biochemical parameters that distinguish the endolysosomal compartments from the extracellular environment have been widely exploited to trigger intracellular drug release from the polymer carriers. Amongst a range of other polymers and polymer nanoparticles that have been investigated over the past 30 years, poly(N-(2-hydroxypropyl) methacrylamide) (PHPMA)-based conjugates have been extensively explored for the endolysosomal release of anticancer drugs. While the modern polymer chemistry toolbox provides many opportunities to tailor the molecular weight and functionality of PHPMA and to introduce features that allow the polymer to respond to the different endolysosomal environments, the development of tools and methods to monitor these processes is also crucial for the future development of advanced delivery systems. The aim of this Thesis is to design dual-functional PHPMA polymers that offer the possibility to control the endolysosomal release of anticancer drug combinations as well as to monitor the PHPMA endolysosomal trafficking. Chapter 1 of this Thesis provides an overview of the different approaches that have been described in literature to control and monitor the intracellular delivery of polymer nanomedicines. Chapter 2 describes a synthetic approach to prepare alpha- and alpha,omega-fluorine labeled pentafluorophenyl methacrylate (PPFMA) polymers via reversible addition fragmentation chain transfer (RAFT) polymerization. In Chapter 3 post-polymerization modification of the alpha-fluorine labeled PPFMA precursor will be used to prepare a series of PHPMA conjugates carrying either the anticancer drug doxorubicin (Dox) or the P-glycoprotein inhibitor zosuquidar (Zos) or both drugs at the polymer side chains. The ability of the conjugates to overcome doxorubicin efflux and therefore reverse P-gp-mediated multidrug resistance in resistant ovarian carcinoma cells will be assessed. Finally, Chapter 4 will study the cellular internalization and endolysosomal trafficking of PHPMA. The synthesis of a dual-labeled PHPMA polymer containing both a fluorescent as well as a fluorinated label will be used for flow cytometry and confocal fluorescence microscopy studies and to demonstrate the potential of nanoscale secondary ion mass spectrometry (NanoSIMS) to map and localize fluorine-containing polymers in cells.

Cellular Uptake and Intracellular Trafficking of Poly(N-(2-Hydroxypropyl) Methacrylamide)

Claudia Battistella, Olivier Burri, Stéphane Laurent Escrig, Romain Guiet, Harm-Anton Klok, Graham Knott, Anders Meibom, Arne Seitz

Cellular uptake and intracellular trafficking of polymer conjugates or polymer nanoparticles is typically monitored using fluorescence-based techniques such as confocal microscopy. While these methods have provided a wealth of insight into the internalization and trafficking of polymers and polymer nanoparticles, they require fluorescent labeling of the polymer or polymer nanoparticle. Because in biological media fluorescent dyes may degrade, be cleaved from the polymer or particle, or even change uptake and trafficking pathways, there is an interest in fluorescent label-free methods to study the interactions between cells and polymer nanomedicines. This article presents a first proof-of-concept that demonstrates the feasibility of NanoSIMS to monitor the intracellular localization of polymer conjugates. For the experiments reported here, poly(N-(2-hydroxypropyl) methacrylamide)) (PHPMA) was selected as a prototypical polymer–drug conjugate. This PHPMA polymer contained a 19F-label at the α-terminus, which was introduced in order to allow NanoSIMS analysis. Prior to the NanoSIMS experiments, the uptake and intracellular trafficking of the polymer was established using confocal microscopy and flow cytometry. These experiments not only provided detailed insight into the kinetics of these processes but were also important to select time points for the NanoSIMS analysis. For the NanoSIMS experiments, HeLa cells were investigated that had been exposed to the PHPMA polymer for a period of 4 or 15 h, which was known to lead to predominant lysosomal accumulation of the polymer. NanoSIMS analysis of resin-embedded and microtomed samples of the cells revealed a punctuated fluorine signal, which was found to colocalize with the sulfur signal that was attributed to the lysosomal compartments. The localization of the polymer in the endolysosomal compartments was confirmed by TEM analysis on the same cell samples. The results of this study illustrate the potential of NanoSIMS to study the uptake and intracellular trafficking of polymer nanomedicines.

2019

Shape memory polymers with controlled time-dependent shape recovery

Charly David Azra

The aim of this thesis has been to investigate the use of heat-activated shape memory polymers (SMPs) as novel smart actuators for the controlled delivery of fluids and their suitability for applications such as low-cost drug delivery. On heating to temperatures in the vicinity of their glass transition temperature, Tg, amorphous SMPs are able to recover their equilibrium shape from a “programmed” temporary shape generated by mechanical deformation, and fixed by cooling to below Tg. This phenomenon is linked to the substantial increase in molecular mobility on heating through the glass transition, and the memory of an equilibrium shape associated a crosslinking network. While SMPs have received considerable attention in the literature, there has to date been relatively little focus on the time-dependence of shape recovery in these materials. There are nevertheless many potential biomedical applications, for example, in which it is necessary to control the actuation rate in SMP-based devices activated by natural heat sources such as the human body, whose temperature may be subject to significant fluctuations. The present work has therefore focused on the time-dependent shape memory effect under isothermal conditions and its sensitivity to temperature variations. The first part of the study involved commercial thermoplastic (physically cross-linked) and thermoset (chemically cross-linked) shape memory polyurethanes (SMPUs). This provided insight into the physical mechanisms underlying the time-dependence of the shape memory effect, which was found to correlate strongly with the viscoelastic behaviour of a given material and the thermomechanical variables associated with the shape memory cycle. It also revealed the importance of the width of the α-transition, ∆Tα , as determined by dynamic mechanical analysis (DMA), and its position on the temperature axis relative to the recovery temperature, Tr. In particular, it was shown that controlled recovery rates could be obtained if Tr corresponded to the onset of the α-transition, and a broad transition led to a reduction in the sensitivity of the shape recovery rate to thermal fluctuations about a given Tr. The next part of the study was devoted to the development of materials optimized for controlled shape recovery under well-defined conditions. The commercial formulations were found to be unsuitable for this purpose, because they offered relatively limited possibilities for tailoring Tg and ∆Tα . Thermoset SMPUs with tunable Tg and ∆Tα were therefore produced in house, based on polytetrahudrofuran (PTHF), 4,4’-diphenylmethane diisocyanate (MDI) and 1,1,1-trimethylolpropane (TMP). The starting point was a literature formulation, which was used to optimize a reactive injection molding (RIM) set-up designed to produce void-free parts with a molding time of less than 3 minutes. These SMPUs were characterized by a PTHF network linked by rigid domains made up of crosslinked MDI and TMP. This made it possible to vary Tg from -60 to 80 °C and ∆Tα from 35 to 100 °C, by varying the molecular weight of the PTHF from 2000 to 650 g/mol, and hence the cross-link density for a given stoichiometric ratio PTHF:MDI:TMP. In order to adjust ∆Tα independently of Tg, flexible segments were introduced to the rigid domains and to the junctions between the rigid domains and the PTHF, using a fourth component, 1,4-butanediol (BDO), or by replacing the TMP with ethoxylated TMP (eTMP). This provided a highly flexible platform for optimizing the shape memory performance. Moreover, the resulting SMPUs showed equilibrium moduli, Ee, of up to 13 MPa, which is relatively high for unreinforced thermosets, and clearly beneficial for fluid displacement where high recovery stresses may be important. To increase Ee further, alumina nanoparticles were dispersed in the SMPUs. This was achieved through ultrasonic, solvent-assisted dispersion of the alumina in PTHF and subsequent curing with the MDI and TMP. Reproducible, void-free, SMPU nanocomposite sheets with alumina contents as high as 15 wt% could be produced in this way within the 3 minute pot-life of the reactive mixtures. These showed a homogeneous dispersion of the alumina (aggregates less than 50 nm in diameter), as confirmed by transmission electron microscopy, leading to a modest increase in Ee to about 21 MPa. This indicated reinforcement to be essentially a geometrical effect (strain amplification), suggesting relatively limited matrix/filler interactions. On the other hand, Rr remained high in these nanocomposites (a decrease of only 5 % on addition of 15 wt% alumina), in contrast with reports in the literature of a significant degradation in shape memory performance for SMPUs containing highly interacting fillers. A linear thermo-viscoelastic model was used to simulate the small strain shape memory effect. Continuous relaxation and retardation spectra, H(τ) and L(τ) respectively, were used to model the time-dependence, and a shift factor, aT(T), was used to model the temperature dependence. To streamline the procedure, a novel characterization method was developed for the determination of aT (T ) from a constant frequency DMA temperature sweep, based on the establishment of an approximate relationship between the storage modulus, the loss modulus and aT (T ). It was hence possible to generate continuous data for aT (T ) from a single DMA run, avoiding the time-consuming and operator-dependent construction of a mastercurve from multiple experiments. Using the Havriliak-Negami parametric functions, H(τ) and L(τ) could be subsequently obtained over a large number of decades of time from the modulus and compliance data. Comparison with results from experimental shape memory data for different model SMPUs, showed this approach to provide a reliable indication of the long-term shape recovery rate. Moreover, this method has great potential for providing rapid insight into the temperature-dependent viscoelastic properties of thermorheologically simple polymers in general, regardless of whether they are being considered specifically for shape memory applications. In the final part of the study, a tailored SMPU nanocomposite formulation was used to produce demonstrators in the form of active shape memory reservoirs, capable of expelling a liquid content under isothermal conditions. The reservoirs consisted of circular membranes (the equilibrium shape), inflated at elevated temperature to form 5 ml blisters and subsequently stabilized in this form by cooling (the programmed shape), using a biaxial deformation set-up incorporating temperature control. This innovative programming procedure made it possible to generate active SMPU reservoirs that could be activated at the skin temperature (32 °C), resulting in low average flow rates ranging between 1 and 5 μL/min over several hours. Such as a device has important potential applications, e.g. skin-temperature activated, low-cost transdermal drug delivery patches.

EPFL2013

Reversion of P-gp-Mediated Drug Resistance in Ovarian Carcinoma Cells with PHPMA-Zosuquidar Conjugates

Claudia Battistella, Harm-Anton Klok

Inhibition of P-glycoprotein (P-gp) transporter is an attractive approach for the reversion of cancer-associated multidrug resistance (MDR). Poly(N-(2-hydroxypropyl) methacrylamide) (PHPMA)-based carriers that are able to release the anticancer drug doxorubicin in the lysosomes have shown promise to reduce P-gp mediated resistance. This is attributed to the release of the drug in close proximity to the nucleus and distant from the P-gp transporter. This work presents a strategy to maximize P-gp inhibition and enhance doxorubicin cytotoxicity in cancer cell by using a dual functional PHPMA conjugate carrying both the anticancer drug doxorubicin and the P-glycoprotein inhibitor zosuquidar (Zos). While doxorubicin was connected to the polymer backbone via a lysosomally cleavable spacer, the P-gp inhibitor Zos was attached by a hydrazone linker in order to promote release in the early stage of the endocytic process and maximize its,cytosolic, concentration in proximity of P-gp transporter. Following Zos modification and determination of its ability to inhibit P-gp, conjugation to the PHPMA polymer backbone resulted in enhanced doxorubicin cytotoxicity in resistant A2780ADR ovarian carcinoma cells. Finally, the incorporation of both Dox and Zos in a single polymer carrier enhanced P-gp inhibition as compared to a control PHPMA conjugate containing only Dox.